Abiraterone Acetate International Brand (Medicinal Forms)


Abiraterone Acetate International Brand (Medicinal Forms)


INDICATIONS AND DOSE:

Metastatic castration-resistant prostate cancer in patients whose disease has progressed during or after treatment with a docetaxel-containing chemotherapy regimen (in combination with prednisone or prednisolone) | Metastatic castration-resistant prostate
cancer in patients who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (in combination with prednisone or prednisolone)
BY MOUTH
Adult: 1 g once daily, for dose of concurrent prednisone or prednisolone—consult product literature

CAUTIONS

Diabetes (increased risk of hyperglycaemia—monitor blood sugar frequently) . history of cardiovascular disease

SIDE-EFFECTS

Common or very common Angina . arrhythmia . atrial fibrillation . diarrhoea . dyspepsia . fractures . haematuria . heart failure . hepatotoxicity . hypertension . hypertriglyceridaemia . hypokalaemia . peripheral oedema . rash . sepsis . tachycardia . urinary tract infection
Uncommon Adrenal insufficiency . myopathy . rhabdomyolysis
Rare Allergic alveolitis

International Brands (Medicinal Forms)

Sr. #
Brand Name
Dosage Form
Pack Size
Price
Manufacturer
1.
Zytiga  250mg
Tablet
120 Tablet
£2,930.00
Janssen-Cilag Ltd
2.
Zytiga  500mg
Tablet
56 Tablet
£2,735.00
Janssen-Cilag Ltd


Reference:

No comments:

Post a Comment